Jeffrey Man Yeung Lo, Veronica Yui Yan Li, Rachel Ka Ying Cheung, Shing Chuen Chow, Kendrick Co Shih, Nicholas Siu Kay Fung, Wai-Ching Lam
{"title":"Comparison of different topical anesthetic methods for intravitreal injections: a randomized crossover study.","authors":"Jeffrey Man Yeung Lo, Veronica Yui Yan Li, Rachel Ka Ying Cheung, Shing Chuen Chow, Kendrick Co Shih, Nicholas Siu Kay Fung, Wai-Ching Lam","doi":"10.1186/s40942-025-00649-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To evaluate the potential adjunctive effect of pledget anesthetic to topical proparacaine applied in a droplet form in patients undergoing intravitreal injections (IVI).</p><p><strong>Method: </strong>This is a single-centre, prospective, randomized, double-blinded crossover study. 60 patients were included. Patients receiving IVI were given topical 0.5% proparacaine drops then randomized in a 1:1 ratio to receive 0.5% proparacaine soaked pledget or normal saline soaked pledget as placebo. The patients would later be crossed over to receive the alternative intervention. Pain was assessed with a visual analog scale (VAS) and questionnaire immediately afterwards, 10-minutes and 20-minutes after injection.</p><p><strong>Result: </strong>Pain intensity as assessed on the visual analogue scale was lower for the placebo group compared to the pledget group immediately (2.51 cm vs. 2.8 cm), 10-minutes (1.81 cm vs. 2.13 cm) and 20-minutes (1.23 cm vs. 1.65 cm) after injection, however this was not statistically significant (p = 0.48, p = 0.43, p = 0.24 respectively). However, in a subgroup of treatment naïve patients, the addition of pledget anesthesia may lower pain and make IVI more tolerable.</p><p><strong>Conclusion: </strong>Additional pledget soaked with proparacaine does not enhance anesthesia compared to solely using topical proparacaine for IVI, except in a subset of treatment naïve patients.</p>","PeriodicalId":14289,"journal":{"name":"International Journal of Retina and Vitreous","volume":"11 1","pages":"36"},"PeriodicalIF":2.4000,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11948794/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Retina and Vitreous","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40942-025-00649-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: To evaluate the potential adjunctive effect of pledget anesthetic to topical proparacaine applied in a droplet form in patients undergoing intravitreal injections (IVI).
Method: This is a single-centre, prospective, randomized, double-blinded crossover study. 60 patients were included. Patients receiving IVI were given topical 0.5% proparacaine drops then randomized in a 1:1 ratio to receive 0.5% proparacaine soaked pledget or normal saline soaked pledget as placebo. The patients would later be crossed over to receive the alternative intervention. Pain was assessed with a visual analog scale (VAS) and questionnaire immediately afterwards, 10-minutes and 20-minutes after injection.
Result: Pain intensity as assessed on the visual analogue scale was lower for the placebo group compared to the pledget group immediately (2.51 cm vs. 2.8 cm), 10-minutes (1.81 cm vs. 2.13 cm) and 20-minutes (1.23 cm vs. 1.65 cm) after injection, however this was not statistically significant (p = 0.48, p = 0.43, p = 0.24 respectively). However, in a subgroup of treatment naïve patients, the addition of pledget anesthesia may lower pain and make IVI more tolerable.
Conclusion: Additional pledget soaked with proparacaine does not enhance anesthesia compared to solely using topical proparacaine for IVI, except in a subset of treatment naïve patients.
研究背景:评价局部丙帕卡因滴剂在玻璃体内注射(IVI)患者中的潜在辅助作用。方法:这是一项单中心、前瞻性、随机、双盲交叉研究。纳入60例患者。接受静脉注射的患者局部给予0.5%丙帕卡因滴剂,然后按1:1的比例随机接受0.5%丙帕卡因浸泡的质料或生理盐水浸泡的质料作为安慰剂。这些患者随后将被交叉接受另一种干预。注射后即刻、注射后10分钟和20分钟分别用视觉模拟量表(VAS)和问卷评估疼痛。结果:与注射后即刻(2.51 cm vs. 2.8 cm)、10分钟(1.81 cm vs. 2.13 cm)和20分钟(1.23 cm vs. 1.65 cm)相比,安慰剂组在视觉模拟量表上评估的疼痛强度较低,但这没有统计学意义(p = 0.48、p = 0.43、p = 0.24)。然而,在治疗naïve患者的一个亚组中,增加麻醉可能会降低疼痛并使IVI更容易耐受。结论:与单纯使用局部丙帕卡因进行IVI相比,额外使用丙帕卡因浸泡的质材并没有增强麻醉,除了治疗naïve患者的一部分。
期刊介绍:
International Journal of Retina and Vitreous focuses on the ophthalmic subspecialty of vitreoretinal disorders. The journal presents original articles on new approaches to diagnosis, outcomes of clinical trials, innovations in pharmacological therapy and surgical techniques, as well as basic science advances that impact clinical practice. Topical areas include, but are not limited to: -Imaging of the retina, choroid and vitreous -Innovations in optical coherence tomography (OCT) -Small-gauge vitrectomy, retinal detachment, chromovitrectomy -Electroretinography (ERG), microperimetry, other functional tests -Intraocular tumors -Retinal pharmacotherapy & drug delivery -Diabetic retinopathy & other vascular diseases -Age-related macular degeneration (AMD) & other macular entities